NCT02259829View on ClinicalTrials.gov

Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

November 30, 2007

Conditions
Healthy
Interventions
DRUG

Telmisartan/Amlodipine

Fixed dose combination tablet

DRUG

Telmisartan

DRUG

Amlodipine

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02259829 - Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter